ArticleOphthalmology science2026
Accuracy and Readability of Chat Generative Pre-Trained Transformer-4 Omni in Answering Ophthalmology Patient Questions.
Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Accuracy and Effectiveness of AI-Powered Systems in Patient Counseling, Education, and Management in Optometry and Related Eye-Care Settings: A Systematic Review.Healthcare (Basel, Switzerland) · 2026Review
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To assess the quality of Chat Generative Pre-Trained Transformer-4 Omni (ChatGPT-4o) responses to questions submitted by patients through Epic MyChart. Design: Retrospective cross-sectional study. Participants: One hundred sixty-five patients who submitted ophthalmology-related questions via Epic MyChart. Methods: Questions asked by ophthalmology clinic patients related to the subspecialties of glaucoma, retina, and cornea via the Epic MyChart at a single institution were evaluated. Nonclinical questions were excluded. Each question was submitted to ChatGPT-4o twice, first without limitations and then after priming the large language model (LLM) to respond at a sixth-grade reading level. The ChatGPT-4o output and subsequent conversations were graded by 2 independent ophthalmologist reviewers as "accurate and complete," "incomplete," or "unacceptable" with respect to the quality of the output. A third subspecialist reviewer provided adjudication in cases of disagreement. Readability of the ChatGPT-4o output was assessed using the Flesch-Kincaid Grade Level and other readability indices. Main Outcome Measures: Quality and readability of answers generated by ChatGPT-4o. Results: Two hundred eighty-five queries asked by 165 patients were analyzed. Overall, 220 (77%) responses were graded as accurate and complete, 49 (17%) as incomplete, and 16 (6%) as unacceptable. The initial 2 reviewers agreed in 87% of the responses generated by ChatGPT-4o. The overall mean Flesch-Kincaid reading grade level was 12.1 ± 2.1. When asked to respond at a sixth-grade reading level, 242 (85%) responses were graded as accurate and complete, 38 (13%) were incomplete, and 5 (2%) were graded as unacceptable. Conclusions: Chat Generative Pre-Trained Transformer-4 Omni usually provides accurate and complete answers to the questions posed by patients to their glaucoma, retina, and cornea subspecialists. A substantial proportion of the responses were, however, graded as incomplete or unacceptable. Chat Generative Pre-Trained Transformer-4 Omni responses required a 12th-grade education level as assessed by Flesch-Kincaid and other readability indices, which may make them difficult for many patients to understand; however, when prompted to do so, the LLM can generate responses at a sixth-grade reading level without a compromise in response quality. Chat Generative Pre-Trained Transformer-4 Omni can potentially be used to answer clinical ophthalmology questions posed by patients; however, additional refinement will be required prior to implementation of such an approach. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.